Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc
WKN: A1JS1K / Symbol: JAZZ / Name: Jazz Pharma / Aktie / Pharmazeutika / Mid Cap /
203,70 €
2,62 %
Jazz Pharmaceuticals (JAZZ) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $195.00 to $258.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Piper Sandler from $232.00 to $301.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) was given a new $256.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Bank of America Corporation from $281.00 to $307.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Discuss J.M. Smucker Corp.